guidelines:
  1: UCLA_Integrated_Staging_System_UISS_for_Renal_Cell_Carcinoma_RCC_guideline.v1
test_cases:
- id: Localized Low, T1, G1, E 0
  input:
    1:
      gt0003|Type of disease present: local::at0006|Localized|
      gt0004|Localized disease - T stage: local::at0009|T1|
      gt0005|Fuhrman nuclear grade: local::at0014|1|
      gt0006|ECOG Performance Status: local::at0019|0|
  expected_output:
    1:
      gt0010|Risk: local::at0022|Low|
      gt0011|Five-year disease-specific survival: local::at0026|91.1%|
- id: Localized Low, T1, G2, E 0
  input:
    1:
      gt0003|Type of disease present: local::at0006|Localized|
      gt0004|Localized disease - T stage: local::at0009|T1|
      gt0005|Fuhrman nuclear grade: local::at0015|2|
      gt0006|ECOG Performance Status: local::at0019|0|
  expected_output:
    1:
      gt0010|Risk: local::at0022|Low|
      gt0011|Five-year disease-specific survival: local::at0026|91.1%|
- id: Localized, Intermediate, T1, G2, E>=1
  input:
    1:
      gt0003|Type of disease present: local::at0006|Localized|
      gt0004|Localized disease - T stage: local::at0009|T1|
      gt0005|Fuhrman nuclear grade: local::at0015|2|
      gt0006|ECOG Performance Status: local::at0020|≥1|
  expected_output:
    1:
      gt0010|Risk: local::at0023|Intermediate|
      gt0011|Five-year disease-specific survival: local::at0027|80.4%|
- id: Localized, Intermediate, T1, G3, E0
  input:
    1:
      gt0003|Type of disease present: local::at0006|Localized|
      gt0004|Localized disease - T stage: local::at0009|T1|
      gt0005|Fuhrman nuclear grade: local::at0016|3|
      gt0006|ECOG Performance Status: local::at0019|0|
  expected_output:
    1:
      gt0010|Risk: local::at0023|Intermediate|
      gt0011|Five-year disease-specific survival: local::at0027|80.4%|
- id: Localized, Intermediate, T1, G3, E>=1
  input:
    1:
      gt0003|Type of disease present: local::at0006|Localized|
      gt0004|Localized disease - T stage: local::at0009|T1|
      gt0005|Fuhrman nuclear grade: local::at0016|3|
      gt0006|ECOG Performance Status: local::at0020|≥1|
  expected_output:
    1:
      gt0010|Risk: local::at0023|Intermediate|
      gt0011|Five-year disease-specific survival: local::at0027|80.4%|
- id: Localized, Intermediate, T1, G4, E0
  input:
    1:
      gt0003|Type of disease present: local::at0006|Localized|
      gt0004|Localized disease - T stage: local::at0009|T1|
      gt0005|Fuhrman nuclear grade: local::at0017|4|
      gt0006|ECOG Performance Status: local::at0019|0|
  expected_output:
    1:
      gt0010|Risk: local::at0023|Intermediate|
      gt0011|Five-year disease-specific survival: local::at0027|80.4%|
- id: Localized, Intermediate, T1, G4, E>=1
  input:
    1:
      gt0003|Type of disease present: local::at0006|Localized|
      gt0004|Localized disease - T stage: local::at0009|T1|
      gt0005|Fuhrman nuclear grade: local::at0017|4|
      gt0006|ECOG Performance Status: local::at0020|≥1|
  expected_output:
    1:
      gt0010|Risk: local::at0023|Intermediate|
      gt0011|Five-year disease-specific survival: local::at0027|80.4%|
- id: Localized, Intermediate, T2-1
  input:
    1:
      gt0003|Type of disease present: local::at0006|Localized|
      gt0004|Localized disease - T stage: local::at0010|T2|
      gt0005|Fuhrman nuclear grade: local::at0017|4|
      gt0006|ECOG Performance Status: local::at0020|≥1|
  expected_output:
    1:
      gt0010|Risk: local::at0023|Intermediate|
      gt0011|Five-year disease-specific survival: local::at0027|80.4%|
- id: Localized, Intermediate, T2-2
  input:
    1:
      gt0003|Type of disease present: local::at0006|Localized|
      gt0004|Localized disease - T stage: local::at0010|T2|
      gt0005|Fuhrman nuclear grade: local::at0015|2|
      gt0006|ECOG Performance Status: local::at0019|0|
  expected_output:
    1:
      gt0010|Risk: local::at0023|Intermediate|
      gt0011|Five-year disease-specific survival: local::at0027|80.4%|
- id: Localized, Intermediate, T3, G1, E0
  input:
    1:
      gt0003|Type of disease present: local::at0006|Localized|
      gt0004|Localized disease - T stage: local::at0011|T3|
      gt0005|Fuhrman nuclear grade: local::at0014|1|
      gt0006|ECOG Performance Status: local::at0019|0|
  expected_output:
    1:
      gt0010|Risk: local::at0023|Intermediate|
      gt0011|Five-year disease-specific survival: local::at0027|80.4%|
- id: Localized, Intermediate, T3, G1, E>=1
  input:
    1:
      gt0003|Type of disease present: local::at0006|Localized|
      gt0004|Localized disease - T stage: local::at0011|T3|
      gt0005|Fuhrman nuclear grade: local::at0014|1|
      gt0006|ECOG Performance Status: local::at0020|≥1|
  expected_output:
    1:
      gt0010|Risk: local::at0023|Intermediate|
      gt0011|Five-year disease-specific survival: local::at0027|80.4%|
- id: Localized, Intermediate, T3, G2, E0
  input:
    1:
      gt0003|Type of disease present: local::at0006|Localized|
      gt0004|Localized disease - T stage: local::at0011|T3|
      gt0005|Fuhrman nuclear grade: local::at0015|2|
      gt0006|ECOG Performance Status: local::at0019|0|
  expected_output:
    1:
      gt0010|Risk: local::at0023|Intermediate|
      gt0011|Five-year disease-specific survival: local::at0027|80.4%|
- id: Localized, Intermediate, T3, G3, E0
  input:
    1:
      gt0003|Type of disease present: local::at0006|Localized|
      gt0004|Localized disease - T stage: local::at0011|T3|
      gt0005|Fuhrman nuclear grade: local::at0016|3|
      gt0006|ECOG Performance Status: local::at0019|0|
  expected_output:
    1:
      gt0010|Risk: local::at0023|Intermediate|
      gt0011|Five-year disease-specific survival: local::at0027|80.4%|
- id: Localized, Intermediate, T3, G4, E0
  input:
    1:
      gt0003|Type of disease present: local::at0006|Localized|
      gt0004|Localized disease - T stage: local::at0011|T3|
      gt0005|Fuhrman nuclear grade: local::at0017|4|
      gt0006|ECOG Performance Status: local::at0019|0|
  expected_output:
    1:
      gt0010|Risk: local::at0023|Intermediate|
      gt0011|Five-year disease-specific survival: local::at0027|80.4%|
- id: Localized, High,T3, G2, E>=1
  input:
    1:
      gt0003|Type of disease present: local::at0006|Localized|
      gt0004|Localized disease - T stage: local::at0011|T3|
      gt0005|Fuhrman nuclear grade: local::at0015|2|
      gt0006|ECOG Performance Status: local::at0020|≥1|
  expected_output:
    1:
      gt0010|Risk: local::at0024|High|
      gt0011|Five-year disease-specific survival: local::at0028|54.7%|
- id: Localized, High,T3, G3, E>=1
  input:
    1:
      gt0003|Type of disease present: local::at0006|Localized|
      gt0004|Localized disease - T stage: local::at0011|T3|
      gt0005|Fuhrman nuclear grade: local::at0016|3|
      gt0006|ECOG Performance Status: local::at0020|≥1|
  expected_output:
    1:
      gt0010|Risk: local::at0024|High|
      gt0011|Five-year disease-specific survival: local::at0028|54.7%|
- id: Localized, High,T3, G4, E>=1
  input:
    1:
      gt0003|Type of disease present: local::at0006|Localized|
      gt0004|Localized disease - T stage: local::at0011|T3|
      gt0005|Fuhrman nuclear grade: local::at0017|4|
      gt0006|ECOG Performance Status: local::at0020|≥1|
  expected_output:
    1:
      gt0010|Risk: local::at0024|High|
      gt0011|Five-year disease-specific survival: local::at0028|54.7%|
- id: Localized, High, T4, G any, E any, Case 1
  input:
    1:
      gt0003|Type of disease present: local::at0006|Localized|
      gt0004|Localized disease - T stage: local::at0012|T4|
      gt0005|Fuhrman nuclear grade: local::at0017|4|
      gt0006|ECOG Performance Status: local::at0020|≥1|
  expected_output:
    1:
      gt0010|Risk: local::at0024|High|
      gt0011|Five-year disease-specific survival: local::at0028|54.7%|
- id: Localized, High, T4, G any, E any Case 2
  input:
    1:
      gt0003|Type of disease present: local::at0006|Localized|
      gt0004|Localized disease - T stage: local::at0012|T4|
      gt0005|Fuhrman nuclear grade: local::at0014|1|
      gt0006|ECOG Performance Status: local::at0020|≥1|
  expected_output:
    1:
      gt0010|Risk: local::at0024|High|
      gt0011|Five-year disease-specific survival: local::at0028|54.7%|
- id: Metastatic, N1M0, Risk Low
  input:
    1:
      gt0003|Type of disease present: local::at0005|Metastatic|
      gt0005|Fuhrman nuclear grade: local::at0014|1|
      gt0006|ECOG Performance Status: local::at0019|0|
      gt0007|Metastatic disease - N stage: local::at0035|N1|
      gt0008|Metastatic disease - M stage: local::at0038|M0|
  expected_output:
    1:
      gt0010|Risk: local::at0022|Low|
      gt0011|Five-year disease-specific survival: local::at0029|32%|
- id: Metastatic, N2M0, Risk Low
  input:
    1:
      gt0003|Type of disease present: local::at0005|Metastatic|
      gt0005|Fuhrman nuclear grade: local::at0014|1|
      gt0006|ECOG Performance Status: local::at0019|0|
      gt0007|Metastatic disease - N stage: local::at0036|N2|
      gt0008|Metastatic disease - M stage: local::at0038|M0|
  expected_output:
    1:
      gt0010|Risk: local::at0022|Low|
      gt0011|Five-year disease-specific survival: local::at0029|32%|
- id: Metastatic, N2M0, G1, E>=1 Risk Inter
  input:
    1:
      gt0003|Type of disease present: local::at0005|Metastatic|
      gt0005|Fuhrman nuclear grade: local::at0014|1|
      gt0006|ECOG Performance Status: local::at0020|≥1|
      gt0007|Metastatic disease - N stage: local::at0036|N2|
      gt0008|Metastatic disease - M stage: local::at0038|M0|
  expected_output:
    1:
      gt0010|Risk: local::at0023|Intermediate|
      gt0011|Five-year disease-specific survival: local::at0030|19.5%|
- id: Metastatic, N2M0, G2, E0, Low
  input:
    1:
      gt0003|Type of disease present: local::at0005|Metastatic|
      gt0005|Fuhrman nuclear grade: local::at0015|2|
      gt0006|ECOG Performance Status: local::at0019|0|
      gt0007|Metastatic disease - N stage: local::at0036|N2|
      gt0008|Metastatic disease - M stage: local::at0038|M0|
  expected_output:
    1:
      gt0010|Risk: local::at0022|Low|
      gt0011|Five-year disease-specific survival: local::at0029|32%|
- id: Metastatic, N2M0, Risk Inter, G2, E>=1
  input:
    1:
      gt0003|Type of disease present: local::at0005|Metastatic|
      gt0005|Fuhrman nuclear grade: local::at0015|2|
      gt0006|ECOG Performance Status: local::at0020|≥1|
      gt0007|Metastatic disease - N stage: local::at0036|N2|
      gt0008|Metastatic disease - M stage: local::at0038|M0|
  expected_output:
    1:
      gt0010|Risk: local::at0023|Intermediate|
      gt0011|Five-year disease-specific survival: local::at0030|19.5%|
- id: Metastatic, N2M0, Risk Inter, G3, E0
  input:
    1:
      gt0003|Type of disease present: local::at0005|Metastatic|
      gt0005|Fuhrman nuclear grade: local::at0016|3|
      gt0006|ECOG Performance Status: local::at0019|0|
      gt0007|Metastatic disease - N stage: local::at0036|N2|
      gt0008|Metastatic disease - M stage: local::at0038|M0|
  expected_output:
    1:
      gt0010|Risk: local::at0023|Intermediate|
      gt0011|Five-year disease-specific survival: local::at0030|19.5%|
- id: Metastatic, N2M0, Risk inter, G3, E>=1
  input:
    1:
      gt0003|Type of disease present: local::at0005|Metastatic|
      gt0005|Fuhrman nuclear grade: local::at0016|3|
      gt0006|ECOG Performance Status: local::at0020|≥1|
      gt0007|Metastatic disease - N stage: local::at0036|N2|
      gt0008|Metastatic disease - M stage: local::at0038|M0|
  expected_output:
    1:
      gt0010|Risk: local::at0023|Intermediate|
      gt0011|Five-year disease-specific survival: local::at0030|19.5%|
- id: Metastatic, N2M0, Risk inter, G4, E0
  input:
    1:
      gt0003|Type of disease present: local::at0005|Metastatic|
      gt0005|Fuhrman nuclear grade: local::at0017|4|
      gt0006|ECOG Performance Status: local::at0019|0|
      gt0007|Metastatic disease - N stage: local::at0036|N2|
      gt0008|Metastatic disease - M stage: local::at0038|M0|
  expected_output:
    1:
      gt0010|Risk: local::at0023|Intermediate|
      gt0011|Five-year disease-specific survival: local::at0030|19.5%|
- id: Metastatic, N2M0, Risk inter, G4, E>=1
  input:
    1:
      gt0003|Type of disease present: local::at0005|Metastatic|
      gt0005|Fuhrman nuclear grade: local::at0017|4|
      gt0006|ECOG Performance Status: local::at0020|≥1|
      gt0007|Metastatic disease - N stage: local::at0036|N2|
      gt0008|Metastatic disease - M stage: local::at0038|M0|
  expected_output:
    1:
      gt0010|Risk: local::at0024|High|
      gt0011|Five-year disease-specific survival: local::at0031|0%|
- id: Metastatic, N2M1, Risk inter, G3, E>=1
  input:
    1:
      gt0003|Type of disease present: local::at0005|Metastatic|
      gt0005|Fuhrman nuclear grade: local::at0017|4|
      gt0006|ECOG Performance Status: local::at0020|≥1|
      gt0007|Metastatic disease - N stage: local::at0036|N2|
      gt0008|Metastatic disease - M stage: local::at0039|M1|
  expected_output:
    1:
      gt0010|Risk: local::at0024|High|
      gt0011|Five-year disease-specific survival: local::at0031|0%|
